MCI patients exhibit significant progressive tau pathology and deposition of amyloid plaques in the olfactory area (CAm), with signal changes from the olfactory nerve possibly predicting the development of dementia (Bathini et al., 2019). The gene discussed is MAPT; the disease is dementia.